The author advocates preventive trials based on the hypothesis that psychosomatic diseases are caused by frustrations induced in some people during their communication with key figures in the family and work groups to which they belong. Certain people are more resistant to such psychosocial stresses by a higher degree of basic security which they owe partly to hereditary factors, partly to an education which was characterized by adequate consistent conditioning. Others, who have been less consistently conditioned are more prone, if frustrated, to develop neurotic or psychosomatic illness. Another important causative factor is the tendency, enforced by the customs of modern Western society, to inhibit the discharge of feelings of frustration in speech or action. The prevention of psychosomatic diseases should therefore be directed at: (a) improvement of education and personality formation in the family, the schools and the work group; (b) improvement of human communication in the family and work groups and in the society at large, and (c) recognition of precursors and early signs of psychosomatic disease, followed by combined medical and psychotherapeutic treatment as a form of secondary prevention.

This content is only available via PDF.
© 1974 S. Karger AG, Basel
1974
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.